150 related articles for article (PubMed ID: 38430119)
21. Time to FIRE NORSE: A single acronym for a heterogeneous presentation. Further information from a case series and discussion of the literature.
Alaskar AM; Aljohani MA; Dionisio S; Asiry MA; Alqadi K
J Neuroimmunol; 2024 Mar; 388():578298. PubMed ID: 38330780
[TBL] [Abstract][Full Text] [Related]
22. Early clinical features of new-onset refractory status epilepticus (NORSE) in adults.
Haanpää A; Laakso SM; Kinnunen A; Kämppi L; Forss N
BMC Neurol; 2022 Dec; 22(1):495. PubMed ID: 36539824
[TBL] [Abstract][Full Text] [Related]
23. New-onset refractory status epilepticus and febrile infection-related epilepsy syndrome.
Specchio N; Pietrafusa N
Dev Med Child Neurol; 2020 Aug; 62(8):897-905. PubMed ID: 32372459
[TBL] [Abstract][Full Text] [Related]
24. Neuropathology of New-Onset Refractory Status Epilepticus (NORSE).
Hanin A; Cespedes J; Huttner A; Strelnikov D; Gopaul M; DiStasio M; Vezzani A; Hirsch LJ; Aronica E
J Neurol; 2023 Aug; 270(8):3688-3702. PubMed ID: 37079033
[TBL] [Abstract][Full Text] [Related]
25. Anakinra usage in febrile infection related epilepsy syndrome: an international cohort.
Lai YC; Muscal E; Wells E; Shukla N; Eschbach K; Hyeong Lee K; Kaliakatsos M; Desai N; Wickström R; Viri M; Freri E; Granata T; Nangia S; Dilena R; Brunklaus A; Wainwright MS; Gorman MP; Stredny CM; Asiri A; Hundallah K; Doja A; Payne E; Wirrell E; Koh S; Carpenter JL; Riviello J
Ann Clin Transl Neurol; 2020 Dec; 7(12):2467-2474. PubMed ID: 33506622
[TBL] [Abstract][Full Text] [Related]
26. New onset refractory status epilepticus: State of the art.
Périn B; Szurhaj W
Rev Neurol (Paris); 2022; 178(1-2):74-83. PubMed ID: 35031143
[TBL] [Abstract][Full Text] [Related]
27. How to Help Your Patients Enroll in the New-Onset Refractory Status Epilepticus (NORSE) and Febrile Infection-Related Epilepsy Syndrome (FIRES) Family Registry, and Other Rare Epilepsy Registries.
Kazazian K; Kellogg M; Wong N; Eschbach K; Moeller RF; Gaspard N; Hirsch LJ; Hocker S; Gofton T
Epilepsy Curr; 2021 Mar; ():1535759721998329. PubMed ID: 33663265
[TBL] [Abstract][Full Text] [Related]
28. Long-term neuropsychological outcomes in children with febrile infection-related epilepsy syndrome (FIRES) treated with anakinra.
Shrestha A; Wood EL; Berrios-Siervo G; Stredny CM; Boyer K; Vega C; Nangia S; Muscal E; Eschbach K
Front Neurol; 2023; 14():1100551. PubMed ID: 36970506
[TBL] [Abstract][Full Text] [Related]
29. Cytokines in New-Onset Refractory Status Epilepticus Predict Outcomes.
Hanin A; Cespedes J; Dorgham K; Pulluru Y; Gopaul M; Gorochov G; Hafler DA; Navarro V; Gaspard N; Hirsch LJ
Ann Neurol; 2023 Jul; 94(1):75-90. PubMed ID: 36871188
[TBL] [Abstract][Full Text] [Related]
30. Febrile infection-related Epilepsy Syndrome (FIRES): a severe encephalopathy with status epilepticus. Literature review and presentation of two new cases.
Pavone P; Corsello G; Raucci U; Lubrano R; Parano E; Ruggieri M; Greco F; Marino S; Falsaperla R
Ital J Pediatr; 2022 Dec; 48(1):199. PubMed ID: 36527084
[TBL] [Abstract][Full Text] [Related]
31. [A case of febrile infection-related epilepsy syndrome requiring prolonged intensive care management: a trial of intravenous ketamine and intrathecal dexamethasone therapy].
Ioku T; Inoue T; Kuki I; Imai K; Yamamoto A; Cho M
Rinsho Shinkeigaku; 2022 Feb; 62(2):123-129. PubMed ID: 35095046
[TBL] [Abstract][Full Text] [Related]
32. Febrile Infection-Related Epilepsy Syndrome Treated Successfully With Anakinra in a 21-Year-Old Woman.
Westbrook C; Subramaniam T; Seagren RM; Tarula E; Co D; Furstenberg-Knauff M; Wallace A; Hsu D; Payne E
WMJ; 2019 Oct; 118(3):135-139. PubMed ID: 31682750
[TBL] [Abstract][Full Text] [Related]
33. New-onset refractory status epilepticus and febrile infection-related epilepsy syndrome.
Sculier C; Gaspard N
Curr Opin Neurol; 2023 Apr; 36(2):110-116. PubMed ID: 36762646
[TBL] [Abstract][Full Text] [Related]
34. Single-Cell Transcriptomic Analyses of Brain Parenchyma in Patients With New-Onset Refractory Status Epilepticus (NORSE).
Hanin A; Zhang L; Huttner AJ; Plu I; Mathon B; Bielle F; Navarro V; Hirsch LJ; Hafler DA
Neurol Neuroimmunol Neuroinflamm; 2024 Jul; 11(4):e200259. PubMed ID: 38810181
[TBL] [Abstract][Full Text] [Related]
35. Successful Treatment of Pediatric FIRES With Anakinra.
Yang JH; Nataraj S; Sattar S
Pediatr Neurol; 2021 Jan; 114():60-61. PubMed ID: 33227629
[No Abstract] [Full Text] [Related]
36. Febrile infection-related epilepsy syndrome treated with anakinra.
Kenney-Jung DL; Vezzani A; Kahoud RJ; LaFrance-Corey RG; Ho ML; Muskardin TW; Wirrell EC; Howe CL; Payne ET
Ann Neurol; 2016 Dec; 80(6):939-945. PubMed ID: 27770579
[TBL] [Abstract][Full Text] [Related]
37. The Increased Interleukin-6 Levels Can Be an Early Diagnostic Marker for New-Onset Refractory Status Epilepticus.
Kwack DW; Kim DW
J Epilepsy Res; 2022 Dec; 12(2):78-81. PubMed ID: 36685741
[TBL] [Abstract][Full Text] [Related]
38. Super-refractory status epilepticus in autoimmune encephalitis treated with interleukin-1 receptor antagonist, anakinra.
Choi CH; Ma SH; Ma KK; Leung H; Mok VC
Epileptic Disord; 2021 Jun; 23(3):500-505. PubMed ID: 34057410
[TBL] [Abstract][Full Text] [Related]
39. Unraveling the enigma of new-onset refractory status epilepticus: a systematic review of aetiologies.
Lattanzi S; Leitinger M; Rocchi C; Salvemini S; Matricardi S; Brigo F; Meletti S; Trinka E
Eur J Neurol; 2022 Feb; 29(2):626-647. PubMed ID: 34661330
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
